Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
boston blog main
boston top stories
life sciences
national blog main
national top stories
new york blog main
4
×
clinical trials
new york top stories
startups
blackstone group
david goldstein
depression
epilepsy
essential tremor
kiran reddy
major depressive disorder
perimenopausal depression
praxis precision medicines
san francisco blog main
san francisco top stories
steven petrou
third rock ventures
adeno-associated virus
aligos therapeutics
antisense oligonucleotide
azacitidine
baker brothers life sciences
benzodiazepine
benzodiazepines
beta-thalassemia
biogen
biotech ipos
blackstone life sciences
blepharitis
cancer
cavion
cephalgia
chemotherapy
What
drugs
4
×
medicines
4
×
research
aims
emerged
new
praxis
precision
therapeutics
adding
ago
aiming
approach
backed
balance
based
biotech
biotechs
build
called
cause
central
ceo
cns
debuts
decibel
developing
disorder
epigenetic
epigenetics
epilepsy
field
flagship’s
focus
forms
genes
genetic
hearing
ipos
kept
Language
unset
Current search:
drugs
×
medicines
×
" new york blog main "
×
@xconomy.com
3 years ago
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs
@xconomy.com
3 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Decibel Therapeutics Strikes a Balance, Adding Regenerative Med Focus
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
